235 related articles for article (PubMed ID: 23969730)
1. P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cells.
Li WH; Qiu Y; Zhang HQ; Liu Y; You JF; Tian XX; Fang WG
Br J Cancer; 2013 Sep; 109(6):1666-75. PubMed ID: 23969730
[TBL] [Abstract][Full Text] [Related]
2. P2Y2 Receptor and EGFR Cooperate to Promote Prostate Cancer Cell Invasion via ERK1/2 Pathway.
Li WH; Qiu Y; Zhang HQ; Tian XX; Fang WG
PLoS One; 2015; 10(7):e0133165. PubMed ID: 26182292
[TBL] [Abstract][Full Text] [Related]
3. [Identification of a new pro-invasion factor in tumor microenvironment: progress in function and mechanism of extracellular ATP].
Fang WG; Tian XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 49(2):188-195. PubMed ID: 28416823
[TBL] [Abstract][Full Text] [Related]
4. ATP-P2Y2-β-catenin axis promotes cell invasion in breast cancer cells.
Zhang JL; Liu Y; Yang H; Zhang HQ; Tian XX; Fang WG
Cancer Sci; 2017 Jul; 108(7):1318-1327. PubMed ID: 28474758
[TBL] [Abstract][Full Text] [Related]
5. P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT-related genes Snail and E-cadherin.
Qiu Y; Liu Y; Li WH; Zhang HQ; Tian XX; Fang WG
Oncol Rep; 2018 Jan; 39(1):138-150. PubMed ID: 29115551
[TBL] [Abstract][Full Text] [Related]
6. P2X7 mediates ATP-driven invasiveness in prostate cancer cells.
Qiu Y; Li WH; Zhang HQ; Liu Y; Tian XX; Fang WG
PLoS One; 2014; 9(12):e114371. PubMed ID: 25486274
[TBL] [Abstract][Full Text] [Related]
7. Purinergic P2Y2 receptors mediate rapid Ca(2+) mobilization, membrane hyperpolarization and nitric oxide production in human vascular endothelial cells.
Raqeeb A; Sheng J; Ao N; Braun AP
Cell Calcium; 2011 Apr; 49(4):240-8. PubMed ID: 21414662
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of FOXK1 Suppresses Proliferation, Migration, and Invasion in Prostate Cancer Cells.
Chen F; Xiong W; Dou K; Ran Q
Oncol Res; 2017 Sep; 25(8):1261-1267. PubMed ID: 28267429
[TBL] [Abstract][Full Text] [Related]
10. Extracellular ATP Induces Vascular Inflammation and Atherosclerosis via Purinergic Receptor Y2 in Mice.
Stachon P; Geis S; Peikert A; Heidenreich A; Michel NA; Ünal F; Hoppe N; Dufner B; Schulte L; Marchini T; Cicko S; Ayata K; Zech A; Wolf D; Hilgendorf I; Willecke F; Reinöhl J; von Zur Mühlen C; Bode C; Idzko M; Zirlik A
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1577-86. PubMed ID: 27339459
[TBL] [Abstract][Full Text] [Related]
11. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
12. Ephrin-A2 promotes prostate cancer metastasis by enhancing angiogenesis and promoting EMT.
Zhao Y; Cai C; Zhang M; Shi L; Wang J; Zhang H; Ma P; Li S
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2013-2023. PubMed ID: 33772606
[TBL] [Abstract][Full Text] [Related]
13. P2Y2R-mediated inflammasome activation is involved in tumor progression in breast cancer cells and in radiotherapy-resistant breast cancer.
Jin H; Ko YS; Kim HJ
Int J Oncol; 2018 Nov; 53(5):1953-1966. PubMed ID: 30226596
[TBL] [Abstract][Full Text] [Related]
14. Purinergic GPCR-integrin interactions drive pancreatic cancer cell invasion.
Tomas Bort E; Joseph MD; Wang Q; Carter EP; Roth NJ; Gibson J; Samadi A; Kocher HM; Simoncelli S; McCormick PJ; Grose RP
Elife; 2023 Mar; 12():. PubMed ID: 36942939
[TBL] [Abstract][Full Text] [Related]
15. Extracellular ATP promotes breast cancer invasion and epithelial-mesenchymal transition via hypoxia-inducible factor 2α signaling.
Yang H; Geng YH; Wang P; Zhou YT; Yang H; Huo YF; Zhang HQ; Li Y; He HY; Tian XX; Fang WG
Cancer Sci; 2019 Aug; 110(8):2456-2470. PubMed ID: 31148343
[TBL] [Abstract][Full Text] [Related]
16. Gastrin-releasing peptide receptor (GRPr) promotes EMT, growth, and invasion in canine prostate cancer.
Elshafae SM; Hassan BB; Supsavhad W; Dirksen WP; Camiener RY; Ding H; Tweedle MF; Rosol TJ
Prostate; 2016 Jun; 76(9):796-809. PubMed ID: 26939805
[TBL] [Abstract][Full Text] [Related]
17. P2Y2 R activation by nucleotides promotes skin wound-healing process.
Jin H; Seo J; Eun SY; Joo YN; Park SW; Lee JH; Chang KC; Kim HJ
Exp Dermatol; 2014 Jul; 23(7):480-5. PubMed ID: 24816122
[TBL] [Abstract][Full Text] [Related]
18. Extracellular ATP induces cytoplasmic and nuclear Ca2+ transients via P2Y2 receptor in human biliary epithelial cancer cells (Mz-Cha-1).
Elsing C; Georgiev T; Hübner CA; Boger R; Stremmel W; Schlenker T
Anticancer Res; 2012 Sep; 32(9):3759-67. PubMed ID: 22993317
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor.
Schumacher D; Strilic B; Sivaraj KK; Wettschureck N; Offermanns S
Cancer Cell; 2013 Jul; 24(1):130-7. PubMed ID: 23810565
[TBL] [Abstract][Full Text] [Related]
20. Collapsin response mediator protein-1 (CRMP1) acts as an invasion and metastasis suppressor of prostate cancer via its suppression of epithelial-mesenchymal transition and remodeling of actin cytoskeleton organization.
Cai G; Wu D; Wang Z; Xu Z; Wong KB; Ng CF; Chan FL; Yu S
Oncogene; 2017 Jan; 36(4):546-558. PubMed ID: 27321179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
